
    
      The RESOLVE II Study is a randomized, sham-controlled, double-blind, parallel arm multicenter
      trial conducted in up to 45 clinical centers (academic and private) across the United States
      in 300 adults with chronic sinusitis, who are indicated for revision surgery because of
      recurring nasal obstruction/congestion symptoms and bilateral ethmoid polyposis.
    
  